Jodi M. Lestner

1.1k total citations
18 papers, 818 citations indexed

About

Jodi M. Lestner is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Jodi M. Lestner has authored 18 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 11 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in Jodi M. Lestner's work include Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (9 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Jodi M. Lestner is often cited by papers focused on Antifungal resistance and susceptibility (12 papers), Fungal Infections and Studies (9 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Jodi M. Lestner collaborates with scholars based in United Kingdom, United States and Belgium. Jodi M. Lestner's co-authors include William Hope, David W. Denning, Susan J. Howard, Eliane M. Billaud, Steven A. Roberts, Caroline B. Moore, Joanne Goodwin, Mike Sharland, Jayesh B. Majithiya and Lea Gregson and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Jodi M. Lestner

18 papers receiving 792 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jodi M. Lestner 567 450 173 82 75 18 818
Diana Mickiene 716 1.3× 504 1.1× 187 1.1× 69 0.8× 94 1.3× 20 879
Joanne Goodwin 669 1.2× 665 1.5× 333 1.9× 39 0.5× 67 0.9× 26 972
Shaun E. Berning 607 1.1× 471 1.0× 199 1.2× 126 1.5× 35 0.5× 19 878
P. Van Rooy 402 0.7× 446 1.0× 75 0.4× 78 1.0× 49 0.7× 18 879
J W Lee 647 1.1× 496 1.1× 75 0.4× 49 0.6× 79 1.1× 13 767
Amy M. Kelaher 724 1.3× 588 1.3× 106 0.6× 68 0.8× 85 1.1× 15 827
Patty Fan‐Havard 438 0.8× 406 0.9× 130 0.8× 182 2.2× 51 0.7× 33 1.1k
D. Facklam 767 1.4× 641 1.4× 139 0.8× 31 0.4× 104 1.4× 17 898
Toru Nakai 380 0.7× 347 0.8× 167 1.0× 93 1.1× 32 0.4× 31 682

Countries citing papers authored by Jodi M. Lestner

Since Specialization
Citations

This map shows the geographic impact of Jodi M. Lestner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi M. Lestner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi M. Lestner more than expected).

Fields of papers citing papers by Jodi M. Lestner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi M. Lestner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi M. Lestner. The network helps show where Jodi M. Lestner may publish in the future.

Co-authorship network of co-authors of Jodi M. Lestner

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi M. Lestner. A scholar is included among the top collaborators of Jodi M. Lestner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi M. Lestner. Jodi M. Lestner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hope, William, Silvia Cicconi, Timothy Felton, et al.. (2019). Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study. Antimicrobial Agents and Chemotherapy. 63(4). 19 indexed citations
2.
Nixon, Gemma L., Laura McEntee, Adam Johnson, et al.. (2018). Repurposing and Reformulation of the Antiparasitic Agent Flubendazole for Treatment of Cryptococcal Meningoencephalitis, a Neglected Fungal Disease. Antimicrobial Agents and Chemotherapy. 62(4). 36 indexed citations
3.
Zimmerman, Matthew, Jodi M. Lestner, Brendan Prideaux, et al.. (2017). Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy. Antimicrobial Agents and Chemotherapy. 61(9). 58 indexed citations
4.
Lestner, Jodi M., Laura McEntee, Adam Johnson, et al.. (2017). Experimental Models of Short Courses of Liposomal Amphotericin B for Induction Therapy for Cryptococcal Meningitis. Antimicrobial Agents and Chemotherapy. 61(6). 27 indexed citations
5.
Lestner, Jodi M., L. Hill, Paul T. Heath, & Mike Sharland. (2016). Vancomycin toxicity in neonates. Current Opinion in Infectious Diseases. 29(3). 237–247. 46 indexed citations
6.
Lestner, Jodi M., Andreas H. Groll, Ghaith Aljayyoussi, et al.. (2016). Population Pharmacokinetics of Liposomal Amphotericin B in Immunocompromised Children. Antimicrobial Agents and Chemotherapy. 60(12). 7340–7346. 30 indexed citations
7.
Barker, Charlotte, et al.. (2014). Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology. Advanced Drug Delivery Reviews. 73. 127–139. 30 indexed citations
8.
Lestner, Jodi M., Ann Versporten, Katja Doerholt, et al.. (2014). Systemic Antifungal Prescribing in Neonates and Children: Outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study. Antimicrobial Agents and Chemotherapy. 59(2). 782–789. 39 indexed citations
9.
Lestner, Jodi M. & William Hope. (2013). Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections. Expert Opinion on Drug Metabolism & Toxicology. 9(7). 911–926. 93 indexed citations
10.
Lestner, Jodi M., et al.. (2012). Unusual neuroradiological features in Schinzel–Giedion syndrome. Clinical Dysmorphology. 21(3). 152–154. 11 indexed citations
11.
Lestner, Jodi M., Richard J. Ellis, & Natalie Canham. (2012). Delineating the 17q24.2–q24.3 microdeletion syndrome phenotype. European Journal of Medical Genetics. 55(12). 700–704. 24 indexed citations
12.
Lestner, Jodi M., P. Brian Smith, Michael Cohen‐Wolkowiez, Daniel K. Benjamin, & William Hope. (2012). Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective. British Journal of Clinical Pharmacology. 75(6). 1381–1395. 34 indexed citations
13.
Lestner, Jodi M., et al.. (2011). Renal impairment with sitagliptin: is there a need for active monitoring of potential renal toxicity?. British Journal of Hospital Medicine. 72(7). 412–413. 10 indexed citations
14.
Howard, Susan J., Jodi M. Lestner, Joanne Sharp, et al.. (2011). Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy. The Journal of Infectious Diseases. 203(9). 1324–1332. 81 indexed citations
15.
Lestner, Jodi M. & David W. Denning. (2010). Tremor: a newly described adverse event with long-term itraconazole therapy. Journal of Neurology Neurosurgery & Psychiatry. 81(3). 327–329. 17 indexed citations
16.
Lestner, Jodi M., Susan J. Howard, Joanne Goodwin, et al.. (2010). Pharmacokinetics and Pharmacodynamics of Amphotericin B Deoxycholate, Liposomal Amphotericin B, and Amphotericin B Lipid Complex in an In Vitro Model of Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. 54(8). 3432–3441. 51 indexed citations
17.
Lestner, Jodi M., Steven A. Roberts, Caroline B. Moore, et al.. (2009). Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring. Clinical Infectious Diseases. 49(6). 928–930. 102 indexed citations
18.
Hope, William, Eliane M. Billaud, Jodi M. Lestner, & David W. Denning. (2008). Therapeutic drug monitoring for triazoles. Current Opinion in Infectious Diseases. 21(6). 580–586. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Diana Mickiene Breakdown of academic impact, for papers by Joanne Goodwin Breakdown of academic impact, for papers by Shaun E. Berning Breakdown of academic impact, for papers by P. Van Rooy Breakdown of academic impact, for papers by J W Lee Breakdown of academic impact, for papers by Amy M. Kelaher Breakdown of academic impact, for papers by Patty Fan‐Havard Breakdown of academic impact, for papers by D. Facklam Breakdown of academic impact, for papers by Toru Nakai
Rankless by CCL
2026